HELX ETF
Franklin Genomic Advancements ETF
NTRA is HELX's largest holding at 9.59% of the fund as of Nov 3, 2026. HELX is Franklin Genomic Advancements ETF.
| # | Ticker | Name | Weight | Cumulative | Shares | Mkt value | Sector | Industry |
|---|---|---|---|---|---|---|---|---|
| 1 | N | Natera IncHealth Care · Biotechnology | 9.59% | 9.6% | 8,775 | $3.41M | Health Care | Biotechnology |
| 2 | G | Guardant Health, IncHealth Care · Biotechnology | 9.52% | 19.1% | 19,345 | $3.39M | Health Care | Biotechnology |
| Sector and industry · Pro | ||||||||
| 3 | K | Krystal Biotech Inc | 4.66% | 23.8% | 5,435 | $1.66M | ||
| 4 | L | Ligand Pharmaceuticals Inc | 4.48% | 28.3% | 5,085 | $1.59M | ||
| 5 | A | Adaptive Biotechnologies Corp | 4.31% | 32.6% | 59,378 | $1.53M | ||
| 6 | T | Twist Bioscience Corp | 3.82% | 36.4% | 9,673 | $1.36M | ||
| 7 | B | BridgeBio Pharma Inc | 3.12% | 39.5% | 15,003 | $1.11M | ||
| 8 | M | Medpace Holdings Inc | 2.82% | 42.3% | 1,509 | $1.00M | ||
| 9 | U | United Therapeutics Corp | 2.76% | 45.1% | 1,634 | $982.6K | ||
| 10 | L | Eli Lilly & Co | 2.72% | 47.8% | 685 | $965.4K | ||
| 11 | V | Vertex Pharmaceuticals Inc | 2.63% | 50.4% | 1,765 | $936.8K | ||
| 12 | R | Regeneron Pharmaceuticals Inc | 2.52% | 53.0% | 919 | $894.5K | ||
| 13 | C | CareDx Inc | 2.27% | 55.2% | 9,142 | $808.8K | ||
| 14 | T | Travere Therapeutics Inc | 2.25% | 57.5% | 16,163 | $798.6K | ||
| 15 | V | Vylor Inc | 2.12% | 59.6% | 10,453 | $752.1K | ||
| 16 | — | Tempus PE | 2.05% | 61.6% | 9,358 | $728.1K | ||
| 17 | G | GRAIL Inc | 2.00% | 63.6% | 5,092 | $710.0K | ||
| 18 | R | Repligen Corp | 1.91% | 65.5% | 3,806 | $678.5K | ||
| 19 | C | Charles River Laboratories International Inc | 1.76% | 67.3% | 1,778 | $625.6K | ||
| 20 | N | Neurocrine Biosciences Inc | 1.62% | 68.9% | 3,494 | $576.0K | ||
| 21 | — | Argenx | 1.40% | 70.3% | 564 | $498.0K | ||
| 22 | J | Jazz Pharmaceuticals PLC | 1.31% | 71.6% | 2,021 | $464.3K | ||
| 23 | K | Kiniksa Pharmaceuticals International PLC Class A | 1.12% | 72.8% | 4,283 | $399.6K | ||
| 24 | P | PTC Therapeutics Inc | 1.10% | 73.9% | 5,723 | $389.9K | ||
| 25 | V | Veracyte Inc | 1.10% | 75.0% | 7,774 | $391.0K | ||
| 26 | H | Hinge Health Inc Class A | 1.06% | 76.0% | 3,218 | $376.0K | ||
| 27 | R | Royalty Pharma | 1.05% | 77.1% | 5,627 | $373.6K | ||
| 28 | — | BioNTech SE ADR | 1.02% | 78.1% | 4,188 | $364.0K | ||
| 29 | I | IQVIA Holdings Inc | 1.02% | 79.1% | 1,377 | $361.6K | ||
| 30 | S | Stoke Therapeutics Inc | 0.98% | 80.1% | 12,969 | $350.0K | ||
| 31 | T | 10x Genomics Inc Class A | 0.98% | 81.1% | 5,351 | $349.4K | ||
| 32 | P | Praxis Precision Medicines Inc | 0.96% | 82.0% | 1,223 | $343.1K | ||
| 33 | S | Sartorius Ag | 0.95% | 83.0% | 1,033 | $338.5K | ||
| 34 | — | Thermo Fisher | 0.94% | 83.9% | 481 | $335.9K | ||
| 35 | — | Samsung Biologics Co Ltd | 0.93% | 84.9% | 305 | $330.3K | ||
| 36 | R | Revolution Medicines Inc | 0.90% | 85.8% | 1,646 | $319.7K | ||
| 37 | — | Genmab AS ADR | 0.85% | 86.6% | 5,461 | $303.2K | ||
| 38 | I | Insmed Inc | 0.85% | 87.5% | 2,909 | $303.8K | ||
| 39 | — | CRISPR Therapeutics AG | 0.81% | 88.3% | 5,748 | $287.3K | ||
| 40 | M | Moderna Inc | 0.72% | 89.0% | 1,117 | $255.2K | ||
| 41 | T | First Tracks Biotherapeutics Inc | 0.70% | 89.7% | 5,381 | $249.4K | ||
| 42 | A | Agilent Technologies Inc | 0.69% | 90.4% | 1,397 | $245.1K | ||
| 43 | — | Cadence Design | 0.67% | 91.0% | 737 | $238.6K | ||
| 44 | A | AnaptysBio Inc | 0.66% | 91.7% | 4,902 | $234.0K | ||
| 45 | B | Beam Therapeutics Inc. | 0.64% | 92.3% | 8,659 | $228.0K | ||
| 46 | E | Eton Pharmaceuticals Inc | 0.61% | 93.0% | 4,227 | $215.4K | ||
| 47 | G | Glaukos Corp | 0.61% | 93.6% | 925 | $215.6K | ||
| 48 | — | Qiagen NV | 0.55% | 94.1% | 3,907 | $196.8K | ||
| 49 | — | AstraZeneca PLC | 0.54% | 94.7% | 1,041 | $191.4K | ||
| 50 | T | TG Therapeutics Inc | 0.53% | 95.2% | 3,123 | $189.7K | ||
| More holdings · Pro | ||||||||
HELX ETF All Holdings
HELX holdings total 71 positions. The top 10 holdings account for 47.8% of the fund, led by Natera Inc at 9.6%, Guardant Health, Inc at 9.5%, Krystal Biotech Inc at 4.7%.
HELX portfolio concentration is moderate, with the top 10 representing 47.8% of total assets. The largest sector exposure is Health Care at 85.5%.
HELX sectors provide a detailed breakdown. HELX overlap shows how holdings compare to other funds in your portfolio.
HELX ETF Holdings
71 of 71 holdings
- 1
Natera Inc
NTRAHealth Care9.59% - 2
Guardant Health, Inc
GHHealth Care9.52% - 3
Krystal Biotech Inc
KRYSHealth Care4.66% - 4
Ligand Pharmaceuticals Inc
LGNDHealth Care4.48% - 5
Adaptive Biotechnologies Corp
ADPTHealth Care4.31% - 6
Twist Bioscience Corp
TWSTHealth Care3.82% - 7
BridgeBio Pharma Inc
BBIOHealth Care3.12% - 8
Medpace Holdings Inc
MEDPHealth Care2.82% - 9
United Therapeutics Corp
UTHRHealth Care2.76% - 10
Eli Lilly & Co
LLYHealth Care2.72% - 11
Vertex Pharmaceuticals Inc
VRTXHealth Care2.63% - 12
Regeneron Pharmaceuticals Inc
REGNHealth Care2.52% - 13
CareDx Inc
CDNAHealth Care2.27% - 14
Travere Therapeutics Inc
TVTXHealth Care2.25% - 15
Vylor Inc
VYLRUnknown2.12% - 16
Tempus PE
TEMInformation Technology2.05% - 17
GRAIL Inc
GRALHealth Care2.00% - 18
Repligen Corp
RGENHealth Care1.91% - 19
Charles River Laboratories International Inc
CRLHealth Care1.76% - 20
Neurocrine Biosciences Inc
NBIXHealth Care1.62% - 21
Argenx
ARGX:ASUnknown1.40% - 22
Jazz Pharmaceuticals PLC
JAZZHealth Care1.31% - 23
Kiniksa Pharmaceuticals International PLC Class A
KNSAUnknown1.12% - 24
PTC Therapeutics Inc
PTCTHealth Care1.10% - 25
Veracyte Inc
VCYTHealth Care1.10% - 26
Hinge Health Inc Class A
HNGEFinancials1.06% - 27
Royalty Pharma
RPRXUnknown1.05% - 28
BioNTech SE ADR
BNTX:FFHealth Care1.02% - 29
IQVIA Holdings Inc
IQVHealth Care1.02% - 30
Stoke Therapeutics Inc
STOKHealth Care0.98% - 31
10x Genomics Inc Class A
TXGHealth Care0.98% - 32
Praxis Precision Medicines Inc
PRAXHealth Care0.96% - 33
Sartorius Ag
SRT:SGUnknown0.95% - 34
Thermo Fisher
TMOHealth Care0.94% - 35
Samsung Biologics Co Ltd
207940:KRUnknown0.93% - 36
Revolution Medicines Inc
RVMDHealth Care0.90% - 37
Genmab AS ADR
GMAB:COHealth Care0.85% - 38
Insmed Inc
INSMHealth Care0.85% - 39
CRISPR Therapeutics AG
CRSP:SMHealth Care0.81% - 40
Moderna Inc
MRNAHealth Care0.72% - 41
First Tracks Biotherapeutics Inc
TRAXUnknown0.70% - 42
Agilent Technologies Inc
AInformation Technology0.69% - 43
Cadence Design
CDNSInformation Technology0.67% - 44
AnaptysBio Inc
ANABHealth Care0.66% - 45
Beam Therapeutics Inc. Com
BEAMHealth Care0.64% - 46
Eton Pharmaceuticals Inc
ETONHealth Care0.61% - 47
Glaukos Corp
GKOSHealth Care0.61% - 48
Qiagen NV
QGEN:SGHealth Care0.55% - 49
AstraZeneca PLC
AZN:LNUnknown0.54% - 50
TG Therapeutics Inc
TGTXHealth Care0.53% - 51
Veradermics Inc
MANEUnknown0.51% - 52
Arcutis Biotherapeutics Inc
ARQTHealth Care0.45% - 53
Roivant Sciences Ltd. Common Shares
ROIV:BMHealth Care0.45% - 54
Axsome Therapeutics Inc
AXSMHealth Care0.42% - 55
Corteva Inc Ctva
CTVAMaterials0.35% - 56
Celcuity Inc
CELCHealth Care0.34% - 57
Cogent Biosciences Inc
COGTHealth Care0.34% - 58
Bio-Rad Laboratories Inc Class A
BIOHealth Care0.29% - 59
Rhythm Pharmaceuticals Inc
RYTMHealth Care0.29% - 60
Tarsus Pharmaceuticals Inc
TARSHealth Care0.27% - 61
BeOne Medicines Ltd ADR
BGNE:SHHealth Care0.26% - 62
Mineralys Therapeutics Inc
MLYSHealth Care0.26% - 63
NEURogene
NGNEUnknown0.17% - 64
GeneDx Holdings Corp Class A
WGSHealth Care0.13% - 65
Liquidia Technologies Inc
LQDAHealth Care0.12% - 66
Samsung Episholdings Co L
0126Z0:KRUnknown0.12% - 67
Cash
Other0.10% - 68
Samsung Biologics Co -Rts (Oct 2026)
Other0.01% - 69
OmniAb Inc
OABIHealth Care0.00% - 70
OmniAb Inc
OABIHealth Care0.00% - 71
Net Current Assets
Other-0.05%
| # | Company | Ticker | Sector | Industry | Weight |
|---|---|---|---|---|---|
| 1 | Natera Inc | NTRA | 9.590% | ||
| 2 | Guardant Health, Inc | GH | 9.520% | ||
| 3 | Krystal Biotech Inc | KRYS | 4.660% | ||
| 4 | Ligand Pharmaceuticals Inc | LGND | 4.480% | ||
| 5 | Adaptive Biotechnologies Corp | ADPT | 4.310% | ||
| 6 | Twist Bioscience Corp | TWST | 3.820% | ||
| 7 | BridgeBio Pharma Inc | BBIO | 3.120% | ||
| 8 | Medpace Holdings Inc | MEDP | 2.820% | ||
| 9 | United Therapeutics Corp | UTHR | 2.760% | ||
| 10 | Eli Lilly & Co | LLY | 2.720% | ||
| 11 | Vertex Pharmaceuticals Inc | VRTX | 2.630% | ||
| 12 | Regeneron Pharmaceuticals Inc | REGN | 2.520% | ||
| 13 | CareDx Inc | CDNA | 2.270% | ||
| 14 | Travere Therapeutics Inc | TVTX | 2.250% | ||
| 15 | Vylor Inc | VYLR | 2.120% | ||
| 16 | Tempus PE | TEM | 2.050% | ||
| 17 | GRAIL Inc | GRAL | 2.000% | ||
| 18 | Repligen Corp | RGEN | 1.910% | ||
| 19 | Charles River Laboratories International Inc | CRL | 1.760% | ||
| 20 | Neurocrine Biosciences Inc | NBIX | 1.620% | ||
| 21 | Argenx | ARGX:AS | 1.400% | ||
| 22 | Jazz Pharmaceuticals PLC | JAZZ | 1.310% | ||
| 23 | Kiniksa Pharmaceuticals International PLC Class A | KNSA | 1.120% | ||
| 24 | PTC Therapeutics Inc | PTCT | 1.100% | ||
| 25 | Veracyte Inc | VCYT | 1.100% | ||
| 26 | Hinge Health Inc Class A | HNGE | 1.060% | ||
| 27 | Royalty Pharma | RPRX | 1.050% | ||
| 28 | BioNTech SE ADR | BNTX:FF | 1.020% | ||
| 29 | IQVIA Holdings Inc | IQV | 1.020% | ||
| 30 | Stoke Therapeutics Inc | STOK | 0.980% | ||
| 31 | 10x Genomics Inc Class A | TXG | 0.980% | ||
| 32 | Praxis Precision Medicines Inc | PRAX | 0.960% | ||
| 33 | Sartorius Ag | SRT:SG | 0.950% | ||
| 34 | Thermo Fisher | TMO | 0.940% | ||
| 35 | Samsung Biologics Co Ltd | 207940:KR | 0.930% | ||
| 36 | Revolution Medicines Inc | RVMD | 0.900% | ||
| 37 | Genmab AS ADR | GMAB:CO | 0.850% | ||
| 38 | Insmed Inc | INSM | 0.850% | ||
| 39 | CRISPR Therapeutics AG | CRSP:SM | 0.810% | ||
| 40 | Moderna Inc | MRNA | 0.720% | ||
| 41 | First Tracks Biotherapeutics Inc | TRAX | 0.700% | ||
| 42 | Agilent Technologies Inc | A | 0.690% | ||
| 43 | Cadence Design | CDNS | 0.670% | ||
| 44 | AnaptysBio Inc | ANAB | 0.660% | ||
| 45 | Beam Therapeutics Inc. Com | BEAM | 0.640% | ||
| 46 | Eton Pharmaceuticals Inc | ETON | 0.610% | ||
| 47 | Glaukos Corp | GKOS | 0.610% | ||
| 48 | Qiagen NV | QGEN:SG | 0.550% | ||
| 49 | AstraZeneca PLC | AZN:LN | 0.540% | ||
| 50 | TG Therapeutics Inc | TGTX | 0.530% | ||
| 51 | Veradermics Inc | MANE | 0.510% | ||
| 52 | Arcutis Biotherapeutics Inc | ARQT | 0.450% | ||
| 53 | Roivant Sciences Ltd. Common Shares | ROIV:BM | 0.450% | ||
| 54 | Axsome Therapeutics Inc | AXSM | 0.420% | ||
| 55 | Corteva Inc Ctva | CTVA | 0.350% | ||
| 56 | Celcuity Inc | CELC | 0.340% | ||
| 57 | Cogent Biosciences Inc | COGT | 0.340% | ||
| 58 | Bio-Rad Laboratories Inc Class A | BIO | 0.290% | ||
| 59 | Rhythm Pharmaceuticals Inc | RYTM | 0.290% | ||
| 60 | Tarsus Pharmaceuticals Inc | TARS | 0.270% | ||
| 61 | BeOne Medicines Ltd ADR | BGNE:SH | 0.260% | ||
| 62 | Mineralys Therapeutics Inc | MLYS | 0.260% | ||
| 63 | NEURogene | NGNE | 0.170% | ||
| 64 | GeneDx Holdings Corp Class A | WGS | 0.130% | ||
| 65 | Liquidia Technologies Inc | LQDA | 0.120% | ||
| 66 | Samsung Episholdings Co L | 0126Z0:KR | 0.120% | ||
| 67 | Cash | - | 0.100% | ||
| 68 | Samsung Biologics Co -Rts (Oct 2026) | - | 0.010% | ||
| 69 | OmniAb Inc | OABI | 0.000% | ||
| 70 | OmniAb Inc | OABI | 0.000% | ||
| 71 | Net Current Assets | - | -0.050% |







































